Advertisement
The Body: The Complete HIV/AIDS Resource Follow Us Follow Us on Facebook Follow Us on Twitter
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

GlaxoSmithKline Spokesman Defends Company's Position on Patent Pools for HIV in Guardian Letter to the Editor

September 10, 2009

In a Guardian letter-to-the editor, Chris Strutt of GlaxoSmithKline responds to the newspaper's recent coverage of the GSK's position on a patent pool for HIV medicines. "Contrary to the impression given in your report ... GSK has been in discussions with UNITAID to better understand their objectives regarding an HIV patent pool," Strutt writes, adding, "We are in no way complacent about HIV ... Fighting this disease requires a multilateral approach and we are fully committed to playing our part" (Strutt, 9/10).

Back to other news for September 2009


This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report.
 
See Also
More on HIV Drug Patent Policies

 

Advertisement